Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 110.8 USD 1.67% Market Closed
Market Cap: 6.7B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+309%
Revenue
Forecast
N/A
Operating Income
Forecast
-7%
Net Income
Forecast
-7%

Wall Street
Price Targets

JAZZ Price Targets Summary
Jazz Pharmaceuticals PLC

Wall Street analysts forecast JAZZ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JAZZ is 192.71 USD with a low forecast of 151.5 USD and a high forecast of 241.5 USD.

JAZZ Lowest Forecast
Wall Street Target
151.5 USD
37% Upside
JAZZ Average Forecast
Wall Street Target
192.71 USD
74% Upside
JAZZ Highest Forecast
Wall Street Target
241.5 USD
118% Upside
Lowest
Price Target
151.5 USD
37% Upside
Average
Price Target
192.71 USD
74% Upside
Highest
Price Target
241.5 USD
118% Upside
Jazz Pharmaceuticals PLC Competitors:
Price Targets
4502
Takeda Pharmaceutical Co Ltd
20% Upside
C
CLN
Celon Pharma SA
9% Upside
4568
Daiichi Sankyo Co Ltd
75% Upside
H
1J5
Hyphens Pharma International Ltd
23% Upside
4502
Takeda Pharmaceutical Co Ltd
20% Upside
C
CLN
Celon Pharma SA
9% Upside
4568
Daiichi Sankyo Co Ltd
75% Upside
H
1J5
Hyphens Pharma International Ltd
23% Upside
S
4565
Sosei Group Corp
113% Upside
N
603707
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
75% Upside
M
MAZE
Maze Therapeutics Inc
192% Upside
A
AETHER
Aether Industries Ltd
31% Upside

Revenue
Forecast

Revenue Estimate
Jazz Pharmaceuticals PLC

For the last 8 years the compound annual growth rate for Jazz Pharmaceuticals PLC's revenue is 13%. The projected CAGR for the next 3 years is 6%.

13%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Jazz Pharmaceuticals PLC

For the last 8 years the compound annual growth rate for Jazz Pharmaceuticals PLC's operating income is 3%. The projected CAGR for the next 3 years is 41%.

3%
Past Growth
41%
Estimated Growth
Estimates Accuracy
-53%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Jazz Pharmaceuticals PLC

For the last 8 years the compound annual growth rate for Jazz Pharmaceuticals PLC's net income is 4%. The projected CAGR for the next 3 years is 39%.

4%
Past Growth
39%
Estimated Growth
Estimates Accuracy
-47%
Average Miss
What are analyst estimates?

See Also

Summary
JAZZ intrinsic value, competitors valuation, and company profile.
DCF Valuation
JAZZ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
JAZZ stock valuation using valuation multiples.
Wall Street Estimates
JAZZ price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
JAZZ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is JAZZ's stock price target?
Price Target
192.71 USD

According to Wall Street analysts, the average 1-year price target for JAZZ is 192.71 USD with a low forecast of 151.5 USD and a high forecast of 241.5 USD.

What is Jazz Pharmaceuticals PLC's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Jazz Pharmaceuticals PLC's revenue is 13%. The projected CAGR for the next 3 years is 6%.

What is Jazz Pharmaceuticals PLC's Operating Income forecast?
Projected CAGR
41%

For the last 8 years the compound annual growth rate for Jazz Pharmaceuticals PLC's operating income is 3%. The projected CAGR for the next 3 years is 41%.

What is Jazz Pharmaceuticals PLC's Net Income forecast?
Projected CAGR
39%

For the last 8 years the compound annual growth rate for Jazz Pharmaceuticals PLC's net income is 4%. The projected CAGR for the next 3 years is 39%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 250,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.